RNS Number : 3549F
AO World plc
07 July 2023
 

 

 

7 July 2022

 

AO World PLC

(the "Company")

 

Additional Listing Application and Total Voting Rights

 

AO World PLC announces that an application has been made for 1,649,459 ordinary shares of 0.25p each (the "Shares") to be admitted to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange.  These shares are being issued to the AO World PLC Employee Benefit Trust in order to satisfy:

 

1.    the release of Share Awards under the terms of The AO 2018 Incentive Plan (FY20 grant and certain early settlements of FY21 and FY22 grants); and

2.    the exercise of options under the AO World Sharesave Scheme (2020 grant (maturity 2023)).  

 

It is expected that admission will become effective on 11 July 2023. When issued, the Shares will rank pari passu with the existing ordinary shares of the Company.

 

Following admission, the Company's issued share capital will consist of 578,570,448 ordinary shares. There are no ordinary shares held in treasury. Therefore, following admission, this figure should be used by shareholders as the denominator for the calculation by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

AO World PLC

Company Secretary

cosec@ao.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSFIFFADFIDIIV